Biologit is the first and only technology company dedicated to global and local literature monitoring for pharmacovigilance (PV). Our AI-powered, GxP-validated platform supports pharmaceutical companies and CROs in meeting regulatory demands efficiently, transparently, and at scale. Built for the unique needs of PV teams, Biologit replaces fragmented systems with a single, intuitive platform that handles all relevant sources, from global open-access databases to regional, subscription-only, and print publications. With up to 70% efficiency gains, it frees PV professionals to focus on strategic safety decisions. Founded by PV expert Dr Nicole Baker and engineering leader Bruno Ohana, Biologit serves many of the world’s top 25 pharma companies across 170 countries.
| Website | http://www.biologit.com |
| Employees | 29 (25 on RocketReach) |
| Founded | 2021 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+19 more
(view full list)
|
| Industry | Software Development |
| Keywords | Life Sciences, Pharmacovigilance, Adverse Event Reporting, Risk Management, Signal Detection, Safety Monitoring, Data Analytics, Regulatory Compliance, Clinical Trial Safety, Big Data Analytics, Predictive Analytics |
| Competitors | The National Institutes of Health, North Carolina State University, Broad Institute of MIT and Harvard, QIAGEN, Benchling, DNASTAR, Geneious, GSL Biotech +25 more (view full list) |
Looking for a particular biologit employee's phone or email?
Nicole Baker is the CEO of biologit.
25 people are employed at biologit.